HCA Holdings Inc. sell Wells Fargo & Company
Start price
25.11.24
/
50%
€307.20
Target price
25.11.25
€303.81
Performance (%)
44.27%
End price
26.11.25
€443.20
Summary
This prediction ended on 26.11.25 with a price of €443.20. The price for HCA Holdings Inc. massively increased, which is bad news for the SELL prediction by Wells_Fargo___Compan. Dividends of €1.35 are taken into consideration when calculating the performance. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| HCA Holdings Inc. | -0.200% | -0.200% | 51.863% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
Comments by Wells_Fargo___Compan for this prediction
In the thread HCA Holdings Inc. diskutieren
HCA Healthcare, Inc. (NYSE: HCA) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $320.00 price target on the stock, down previously from $400.00.
Ratings data for HCA provided by MarketBeat
In the thread Trading HCA Holdings Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten